Table Of Content

10/01/2019 LD-2 Disclosure Form Clerk of the House of Representatives Secretary of the Senate Legislative Resource Center Office of Public Records B-106 Cannon Building 232 Hart Building Washington, DC 20515 Washington, DC 20510 LOBBYING REPORT http://lobbyingdisclosure.house.gov http://www.senate.gov/lobby Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page 1. Registrant Name Organization/Lobbying Firm Self Employed Individual BAYER CORPORATION (consolidated report) 2. Address Address1 701 Pennsylvania Ave., NW Suite 720 Address2 City WASHINGTON State DC Zip Code 20004 Country USA 3. Principal place of business (if different than line 2) City State Zip Code Country 4a. Contact Name b. Telephone Number c. E-mail 5. Senate ID# Mr. JONATHAN COLLUM 2027378900 [email protected] 5632-12 7. Client Name Self Check if client is a state or local government or instrumentality 6. House ID# BAYER CORPORATION (consolidated report) 312570000 TYPE OF REPORT 8. Year 2013 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31) 9. Check if this filing amends a previously filed version of this report 10. Check if this is a Termination Report Termination Date 11. No Lobbying Issue Activity INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 12. Lobbying 13. Organizations INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were: Less than $5,000 Less than $5,000 $5,000 or more $ $5,000 or more $ 1,000,000.00 Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the 14. REPORTING Check box to indicate expense accounting method. registrant by any other entity for lobbying activities on behalf of the See instructions for description of options. client). Method A. Reporting amounts using LDA definitions only Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code Signature Digitally Signed By: Christopher Leahy, Head of Government Relations Date 01/21/2014 https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 1/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code AGR 16. Specific lobbying issues S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Biotechnology, Winter Wheat Cereals Project and Pollinators. S. 809/H.R. 1699, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R.2692, Saving America's Pollinators Act of 2013. Provisions related to suspension of pesticide registrations. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Jean Reimers Matthew Perin 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 2/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code BAN 16. Specific lobbying issues S1106, Sensible Accounting to Value Energy Act of 2013. All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Julie Van Egmond Dakotah Smith 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 3/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code CHM 16. Specific lobbying issues S696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Julie Van Egmond Dakotah Smith 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 4/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code EDU 16. Specific lobbying issues S 553/HR 1125, Veterinary Medicine Loan Repayment Program Enhancement Act. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Donna Stephens 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 5/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code ENG 16. Specific lobbying issues S761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030. S1392/ HR 1616, Energy Savings and Industrial Competitiveness Act of 2013 - all provisions pertaining to the Shaheen Portman Act S. 761 regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Dakotah Smith Julie Van Egmond 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 6/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code HCR 16. Specific lobbying issues H.R. 1150, Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases. Title II, General provisions in the bill. S. 1256, Preventing Antibiotic Resistance Act of 2013. A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases. S.959/HR 3204, Pharmaceutical Compounding Quality and Accountability Act. General provisions of the bill. HR 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. 17. House(s) of Congress and Federal agencies Check if None U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Donna Stephens Julie Corcoran Thomas Lilburn 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 7/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code HOM 16. Specific lobbying issues Monitor the implementation of the FY2013 Continuing Appropriations Act, P.L. 113-6. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Donna Stephens 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 8/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code MMM 16. Specific lobbying issues S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Need for tranparency on the CMS preventative maintenance directive for medical equipment. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Thoms Lilburn Robert Thomas 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 9/14 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code PHA 16. Specific lobbying issues HR 3204, Drug Quality and Security Act. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding. 17. House(s) of Congress and Federal agencies Check if None U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Thomas Lilburn 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=F96E8A94-9B12-42EF-9C8B-36B0B3283FDE&filingTypeID=78 10/14